DEVELOPMENT AND VALIDATION OF STABILITY INDICATING ASSAY DEVELOPMENT FOR ENZALUTAMIDE IN STANDARD AND DOSAGE FORM BY RP-HPLC METHOD Authors: Patel T , KAMANI K, RATHI S
ABSTRACT
A simple, rapid, accurate and economic stability indicating method has been developed for estimation
of Enzalutamide from bulk and pharmaceutical formulation. In RP-HPLC method, chromatographic
separation was achieved on Phenomenax, C18 (150mm×4.6mm×5m) column using Acetonitrile:
Water (65:35 v/v) as the mobile phase with detection at 236 nm. The drug was subjected to acidic,
alkali, oxidative, thermal and photolytic stress conditions whereas Capsule was subjected to thermal
and photolytic stress conditions. The drug follows linearity in the concentration range 10-50 ?g/mL
with correlation coefficient value 0.9995. The proposed method was applied to pharmaceutical
formulation and % amount of drug estimated 101.09% was found in good agreement with the
label claim. The accuracy of the method was checked by recovery experiment performed at three
different levels i.e., 80%, 100% and 120%. The % recovery was found to be in the range 99.45-
100.4%. The low values of %R.S.D. are indicative of the accuracy and reproducibility of the
method. The precision of the method was studied as an intra-day, inter-day variations and
repeatability. The %R.S.D. value less than 2 indicates that the method is precise. Ruggedness of the
proposed method was studied with the help of two analysts. The above method was a rapid and cost-
effective quality-control tool for routine analysis of Enzalutamide in bulk and in pharmaceutical
dosage form.
Keywords: Enzalutamide; Validation; Stability indicating, RP-HPLC, Quantitative determination, Methanol Publication date: 01/07/2023 https://ijbpas.com/pdf/2023/July/MS_IJBPAS_2023_7276.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2023/12.7.7276